Who invested in CANbridge Pharmaceuticals?
CANbridge Pharmaceuticals's investors include Qiming Venture Partners, RA Capital Management, General Atlantic and Casdin Capital.
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$13Mraised across 1 round since 2025, from 1 source
CANbridge Pharmaceuticals's investors include Qiming Venture Partners, RA Capital Management, General Atlantic and Casdin Capital.
CANbridge Pharmaceuticals has raised $13M across 1 round since 2025.
CANbridge Pharmaceuticals's most recent round was an Undisclosed round of $13M in Aug 2025.
Its most recent round, $13M in Aug 2025, is also its largest on record.
CANbridge Pharmaceuticals's first round on record, in Aug 2025, was backed by Qiming Venture Partners, RA Capital Management and General Atlantic and 1 others.
CANbridge Pharmaceuticals's latest named round is an Undisclosed round, in Aug 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.